In today’s environment, no industry is immune from claims of workplace harassment. Allegations can not only tarnish a company’s — and a board’s — reputation, and impair shareholder value, but also imperil a company’s existence. And when allegations do arise, it’s essential that boards act quickly. 

Doreen Lilienfeld, Global Head of Shearman & Sterling’s Governance & Advisory Group and Head of the Healthcare Industry Group, provides a thoughtful approach to addressing sexual harassment claims at the board level in this article, published in Bio Century.

Read the full article here.